BioLase Inc. reported a net loss of $3.5 million in the third quarter, an improvement over the previous quarter and the third quarter of 2013. Net revenue for this year’s third quarter was $12.7 million, compared to $10.2 million in the second quarter and $12.3 million in the third quarter of 2013. The company said it saw a significant increase in sales of its core WaterLase systems, as well as increased sales of distributed imaging equipment. CEO Jeffrey M. Nugent said the company is following a new business strategy focused on customer satisfaction, product quality, innovation, accountability and efficiency. For more information, visit www.biolase.com.